SOBRAFO Farmácia Oncológica
SOBRAFO Título de Especialista em Farmácia Oncológica (Brazil)
Farmacia Clinica OncologicaEnglish
Exam overviewPractice session
Why does concomitant administration of Proton Pump Inhibitors (PPIs, e.g., Omeprazole) or H2-Receptor Antagonists significantly decrease the oral bioavailability and clinical efficacy of oral Tyrosine Kinase Inhibitors (such as Erlotinib, Dasatinib, and Pazopanib)?
Loading your practice session…